Why is the penumbra important in acute stroke management and how does it influence interpretation of CT perfusion imaging when deciding to administer tenecteplase (tenecteplase)?

Why Penumbra Matters in Code Stroke and CT Perfusion Interpretation for TNK

The penumbra represents salvageable brain tissue at risk of infarction—identifying it on CT perfusion is critical because it defines which patients will benefit from thrombolytic therapy like tenecteplase (TNK), as treating patients with viable penumbra improves functional outcomes while avoiding treatment in those with predominantly dead tissue reduces hemorrhagic complications without benefit.

The Core Concept: Dead vs. Salvageable Tissue

The fundamental principle in acute stroke management is distinguishing between:

• Ischemic core: Irreversibly infarcted tissue (dead brain)
• Penumbra: Ischemic but viable tissue that can be rescued if blood flow is restored quickly

The penumbra is the therapeutic target—this is the tissue you're trying to save with TNK 1. The neurological examination alone cannot differentiate between core and penumbra, which is why perfusion imaging became essential 1.

How CT Perfusion Defines Core and Penumbra

When interpreting CT perfusion for TNK decisions, use these specific thresholds:

Penumbra Definition

• Delay time (Tmax) ≥ 3 seconds most accurately defines penumbra 2
• Alternatively, Tmax > 6 seconds is used in major trials 3
• This represents tissue with delayed perfusion but not yet dead

Core Definition

• Relative cerebral blood flow (rCBF) ≤ 30% within the delayed perfusion region 2
• Ischemic core volume < 70 mL was used as a cutoff in EXTEND-IA 3
• Some protocols use < 100 mL as the upper limit 3

The Mismatch Ratio

A favorable penumbral profile requires:

• Mismatch ratio > 1.2 to 1.8 (penumbra volume/core volume) 3, 4
• Absolute mismatch volume > 10-15 mL 3, 4
• This ensures there's enough salvageable tissue to justify treatment risks

Applying This to TNK Decision-Making

Standard Time Window (0-4.5 hours)

• CT perfusion is not mandatory for TNK administration
• Non-contrast CT to exclude hemorrhage is sufficient
• However, perfusion imaging helps predict outcomes and hemorrhage risk 1

Extended Time Window (4.5-24 hours)

CT perfusion becomes essential 4. The CHABLIS-T II trial demonstrated that TNK in this window requires:

1. Favorable penumbral profile (mismatch ratio > 1.2, absolute difference > 10 mL)
2. Ischemic core < 70 mL
3. Large/medium vessel occlusion present

This approach increased reperfusion rates (33.3% vs 10.8%) without increasing symptomatic intracranial hemorrhage 4.

When EVT is Unavailable

TNK provides greater benefit when endovascular thrombectomy cannot be performed 5. In the non-EVT subgroup:

• Excellent functional outcome improved (OR 1.46)
• Good functional outcome improved (OR 1.50)
• Early neurological improvement increased (OR 3.21)

This makes penumbra assessment even more critical in resource-limited settings where TNK may be the only reperfusion option 5.

Critical Pitfalls to Avoid

False Penumbras

Be aware of five conditions that mimic penumbra on CT perfusion 6:

1. Upstream flow restriction (e.g., carotid stenosis causing benign oligemia)
2. Evolution of ischemic change (imaging during transition)
3. Vascular dysregulation (loss of autoregulation)
4. Head positioning artifacts (angled acquisition)
5. Circle of Willis variants (asymmetric normal flow patterns)

Always correlate CT perfusion with:

• Non-contrast CT findings
• CT angiography vessel patency
• Clinical presentation and NIHSS score 6

Volume Assessment Method

Use volumetric software analysis rather than visual estimation 7:

• Volumetric mismatch assessment shows excellent inter-rater reliability (ICC 0.961)
• Visual estimation has poor inter-rater agreement (ICC 0.415)
• ASPECTS-based assessment has the worst reliability (κ 0.133) 7

Safety Profile of TNK

Recent meta-analyses confirm TNK's safety regarding hemorrhagic complications 8, 9:

• Symptomatic ICH rate: 3.09% with TNK vs 2.49% with alteplase (not significantly different)
• Overall ICH: No difference between TNK and alteplase
• Mortality: Similar between TNK and alteplase

The 0.25 mg/kg dose shows equivalent safety to 0.4 mg/kg 8.

Practical Algorithm for TNK Decision Using CT Perfusion

For patients presenting 4.5-24 hours after last known well:

1. Obtain whole brain CT perfusion (100 mm z-axis coverage minimum)
2. Calculate core volume (rCBF ≤ 30% or < 70 mL absolute)
3. Calculate penumbra volume (Tmax ≥ 3-6 seconds)
4. Determine mismatch ratio (penumbra/core)
5. Give TNK if:
   • Mismatch ratio > 1.2
   • Absolute mismatch > 10 mL
   • Core < 70 mL
   • Large/medium vessel occlusion confirmed
6. Withhold TNK if:
   • Core > 70-100 mL (high hemorrhage risk, minimal salvageable tissue)
   • No significant mismatch (tissue already infarcted)
   • Suspected false penumbra pattern

The penumbra essentially represents your therapeutic window made visible—it transforms "time is brain" into "tissue is brain," allowing individualized treatment decisions based on actual tissue viability rather than arbitrary time cutoffs 10.